![India: People will have easier access to tuberculosis treatment after patent extension rejected | Green Left India: People will have easier access to tuberculosis treatment after patent extension rejected | Green Left](https://www.greenleft.org.au/sites/default/files/glw_article_pic_-_wide_-_850_x_690_px157_0.png)
India: People will have easier access to tuberculosis treatment after patent extension rejected | Green Left
![endTB on X: "The first shipment of #bedaquiline has arrived in Peru. Let's get those drugs into patients! Thanks @UNITAID https://t.co/0mfqMplZGy" / X endTB on X: "The first shipment of #bedaquiline has arrived in Peru. Let's get those drugs into patients! Thanks @UNITAID https://t.co/0mfqMplZGy" / X](https://pbs.twimg.com/media/CZfbGyDW0AEQhtq.jpg)
endTB on X: "The first shipment of #bedaquiline has arrived in Peru. Let's get those drugs into patients! Thanks @UNITAID https://t.co/0mfqMplZGy" / X
![Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB) - Clinical Trials Arena Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB) - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-22.jpg)
Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB) - Clinical Trials Arena
![Find Sirturo bedaquiline 100 mg tablet by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App Find Sirturo bedaquiline 100 mg tablet by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App](https://production-uploads-cdn.anar.biz/uploads/image/image/11633748/medium_4191b238-c31d-48df-a81a-04bef7cd6586_1664882477830_photo.webp)
Find Sirturo bedaquiline 100 mg tablet by Henrique Pharmacy near me | Bhandup East, Mumbai, Maharashtra | Anar B2B Business App
![SAgovnews on X: ".@HealthZA will make #Bedaquiline available to all eligible Rifampicin Resistant #TB patients to reduce side effects and improve health outcomes. https://t.co/HQPeetJNto https://t.co/xY9sWNUZHA" / X SAgovnews on X: ".@HealthZA will make #Bedaquiline available to all eligible Rifampicin Resistant #TB patients to reduce side effects and improve health outcomes. https://t.co/HQPeetJNto https://t.co/xY9sWNUZHA" / X](https://pbs.twimg.com/media/DgC-XL5XcAE-2Ip.jpg)
SAgovnews on X: ".@HealthZA will make #Bedaquiline available to all eligible Rifampicin Resistant #TB patients to reduce side effects and improve health outcomes. https://t.co/HQPeetJNto https://t.co/xY9sWNUZHA" / X
![MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics | Médecins Sans Frontières MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics | Médecins Sans Frontières](https://www.msfaccess.org/sites/default/files/2023-07/TB_Ukraine_Medication_OksanaParafeniuk_2018_MSF248559_3800px_v1.jpg)
MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics | Médecins Sans Frontières
![MSF demands J&J give up its patent monopoly on TB drug to put lives over profits | Médecins Sans Frontières Access Campaign MSF demands J&J give up its patent monopoly on TB drug to put lives over profits | Médecins Sans Frontières Access Campaign](https://www.msfaccess.org/sites/default/files/2023-01/TB_Belarus_Bedaquiline_2022_AlexandraSodokova_MSB137912_3800px.jpg)
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits | Médecins Sans Frontières Access Campaign
![These highlights do not include all the information needed to use SIRTURO safely and effectively. See full prescribing information for SIRTURO. SIRTURO ®(bedaquiline) tablets, for oral use Initial U.S. Approval: 2012 These highlights do not include all the information needed to use SIRTURO safely and effectively. See full prescribing information for SIRTURO. SIRTURO ®(bedaquiline) tablets, for oral use Initial U.S. Approval: 2012](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=sirturo-03.jpg&id=736931)